RxDoctor Payments Data

Robert Spady, MD

Internal Medicine · Moscow, IDNPI 1053329490

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 25th percentile of 289 internal medicine providers in Idaho.

See all internal medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$494,331
Medicare patients
314
Services billed
4,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban236$123,943
XareltoRivaroxaban43$37,126
HumalogInsulin Lispro23$13,260
Breo ElliptaFluticasone/Vilanterol30$12,520
MyrbetriqMirabegron44$11,724
Spiriva HandihalerTiotropium Bromide21$11,410
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$9,857
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$8,399
OxycontinOxycodone Hcl14$8,065
LokelmaSodium Zirconium Cyclosilicate19$7,415
Gabapentin216$6,510
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen194$6,223
Lantus SolostarInsulin Glargine,hum.Rec.Anlog67$6,054
Combivent RespimatIpratropium/Albuterol Sulfate12$5,474
LantusInsulin Glargine,hum.Rec.Anlog23$5,335

Paid to pharmacies, not to this prescriber.

Other internal medicine in Moscow

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →